MRNS - Margin dodolan resik Marinus Pharmaceuticals, Inc.

MRNS (Marinus Pharmaceuticals, Inc.) - tandha merek perusahaan

Geopolitical risks and raw material supply disruptions are weighing on Marinus Pharmaceuticals (MRNS), as evidenced by the volatility on the net profitability chart. Niche leadership in epilepsy therapy across various age groups stabilizes the business, yet the failure of final drug tests is forcing the company to cut costs. The current -446.50 figure reflects the state of the sales margin metric amid the search for strategic partners.

Tingkat bathi resik Marinus Pharmaceuticals (MRNS): kanggo periode 04.07.2022 - 22.02.2025

MRNS (Marinus): rincian analitis lan laporan miturut indikator

Analisis dhasar perusahaan:Marinus Pharma - MRNS
Barang unggulan Marinus Pharmaceuticals Inc

The commercialization of Ztalmy and expansion into the rare epilepsy segment drive the current operational efficiency of Marinus Pharmaceuticals (MRNS). This indicator is calculated as the ratio of net income to revenue, measuring the portion of every dollar of income remaining after all expenses. Analyzing the net profit margin allows for the identification of hidden costs prior to official reports. This trend captures the resilience of the business model as the drug scales. Stable margin growth signals to the market that the invested capital is protected.

Analisis perusahaan pesaing

BIIB: Margin dodolan resik|Margin resik Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Margin dodolan resik|AXSM: Tingkat bathi resik|Margin resik acadia-pharm.com (ACAD)|Margin dodolan resik Xenon Pharmaceuticals (XENE)|Margin resik Viking Therapeutics VKTX|Tingkat bathi resik SUPN|CPRX - Margin resik|Margin resik Denali Therapeutics|HRMY: Margin dodolan resik|Biohaven - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik AMLX|Trevi Therapeutics, Inc. (TRVI) - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik PRAX (Praxis Medicines)|Anavex Corp - Rentabilitas dodolan resik|Margin resik CeriBell CBLL|Margin dodolan perusahaan Prothena Biosciences (PRTA)|ALEC: Rentabilitas dodolan miturut bathi resik|ANNX - Margin dodolan resik|Omeros Corp. (OMER) - Margin resik|Margin resik Neurogene Inc. (NGNE)|Rentabilitas dodolan miturut bathi resik ACIU|Margin resik VYGR|Margin resik Neumora (NMRA)|SCLX - Margin resik|Margin dodolan resik TVGN (Tevogen Bio Holdings Inc.)|Tingkat bathi resik ACOG|Cognition Therapeutics Inc. - Margin dodolan resik|IKT - Margin dodolan resik|SAVA: Margin dodolan resik|Assertio Holdings, Inc. - Tingkat bathi resik|COYA (Coya) - Margin dodolan resik|Rentabilitas dodolan resik VTGN (Vistagen Therapeutics)|Margin resik Ovid Rx (OVID)|Acumen Pharmaceuticals - Rentabilitas dodolan resik|Margin resik CervoMed, Inc. CRVO|Margin dodolan resik Alterity Therapeutics ATHE|CLNN: Rentabilitas dodolan miturut bathi resik|PEPG (pepgen.com) - Rentabilitas dodolan resik|Jupiter Neurosciences Inc (JUNS) - Margin resik|Relmada Therapeutics - Tingkat bathi resik|ANVS (Annovis Bio Inc) - Margin dodolan resik|GRCE: Tingkat bathi resik|Margin resik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Tingkat bathi resik|Margin resik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Margin resik|MTVA: Rentabilitas dodolan miturut bathi resik|NeurAxis, Inc (NRXS) - Rentabilitas dodolan miturut bathi resik|HSDT: Margin dodolan resik|PASG - Margin dodolan perusahaan|Margin resik Neuphoria Therapeutics, Inc.|Margin resik NERV|Margin dodolan resik ATHA|ADXN (Addex Therapeutics Ltd) - Tingkat bathi resik|Margin resik alzamend.com ALZN|Margin dodolan perusahaan Cyclerion Therapeutics (CYCN)|Protagenic - Margin dodolan resik|Tingkat bathi resik KTTA (Pasithea Therapeutics Corp)|CRGT: Margin dodolan resik|Avenue Therapeutics Inc. (ATXI) - Margin dodolan resik|BCLI (BrainStorm Cell Therapeutics Inc.) - Margin dodolan resik|Margin dodolan resik Cara Therapeutics Inc|Margin resik Chromocell Therapeutics (CHRO)|Rentabilitas resik perusahaan ELYM|Margin resik Intra-Cellular ITCI|LBPH: Rentabilitas dodolan resik|NKGen Biotech Corp - Margin dodolan resik|Tingkat bathi resik NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik SNPX|Rentabilitas dodolan miturut bathi resik TRVN|Margin resik VIGL|Margin dodolan resik WENA|Margin dodolan perusahaan Cerevel